MAPT and early-onset autosomal dominant Alzheimer disease: Individual genetic ablation of Fyn or Tau appears to be protective against aberrant excitatory neuronal activities in Alzheimer’s disease and epilepsy models [107], although it remains unclear whether the ablation of both Fyn and Tau would elicit more profound antiseizure and neuroprotective effects.